Explorer les evidences

505 introductionsFive hundred five SARS-CoV-2 introductions in Kenya between March 2020 and September 2022 were associated with the Omicron variant.

KenyaCOVID-19observé March 2020 – September 2022publié 2022The genomic epidemiology of SARS-CoV-2 variants of concern in Kenyaeurope_pmcdocument de 8 observationsDOI 10.1101/2022.10.26.22281446

1 053 casesAmong 14,562 acute respiratory infection cases recruited in coastal Kenya by February 2025, 1,053 (7.2%) tested positive for SARS-CoV-2.

KenyaCOVID-19observé February 2025publié 2025Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020 - 2025europe_pmcdocument de 8 observations

91,6 %At health facility level, 91.6% of SARS-CoV-2 tests were from individuals without symptoms in the Coastal part of Kenya between 17th March 2020 and 30th June 2021.

KenyaCOVID-19observé 17th March 2020 to 30th June 2021publié 2022Wellcome open researcheurope_pmcdocument de 10 observations

11 %11% of people living with HIV in Kibera did not access health facilities due to fear of contracting COVID-19, government regulations, and lack of personal protective equipment.

KenyaCOVID-19 · VIH/sidapublié 2021International journal of environmental research and public healthPubMeddocument de 7 observations

17 975 casesAs of July 30, 2020, Kenya reported 17975 cases of COVID-19.

KenyaCOVID-19observé July 30, 2020publié 2022Journal of global healthPubMeddocument de 24 observations

66 %SARS-CoV-2 seropositivity was found in 66% of the 126 mothers in Nairobi, Kenya.

KenyaCOVID-19observé between May 1, 2020-February 1, 2022publié 2023PloS onePubMeddocument de 8 observations

29 introductionsTwenty-nine SARS-CoV-2 introductions in Kenya between March 2020 and September 2022 were associated with the A.23.1 variant.

KenyaA.23.1 variant · COVID-19observé March 2020 – September 2022publié 2022The genomic epidemiology of SARS-CoV-2 variants of concern in Kenyaeurope_pmcdocument de 8 observationsDOI 10.1101/2022.10.26.22281446

1,99 odds_ratioThe odds of developing COVID-19 symptoms were higher among cases aged above 60 years (odds ratio = 1.99, P = 0.007).

KenyaCOVID-19publié 2022Journal of global healthPubMeddocument de 24 observations

The FY.4 variant led to a large local outbreak in Kenya.

KenyaCOVID-19publié 2025Virus evolutioneurope_pmcdocument de 4 observations

1,37 aORSRI patients presenting with cough were more likely to have SARS-CoV-2 infection compared to those who did not, with an adjusted odds ratio of 1.37.

KenyaCOVID-19observé July 2022 to October 2023publié 2026VaccinePubMeddocument de 8 observations

10,3 %SARS-CoV-2 prevalence was 10.3% among people living without HIV and 6.3% among persons living with HIV in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.

Kenya · Nigeria · Ouganda · TanzanieCOVID-19observé 19 July 2022 to 1 March 2024publié 2025BMC infectious diseasesPubMeddocument de 8 observations

6 mgDexamethasone six milligrams once daily for ten days has demonstrated mortality benefit in severe and critical COVID-19 infection.

KenyaCOVID-19publié 2024PloS onePubMeddocument de 18 observations

78 introductionsSeventy-eight SARS-CoV-2 introductions in Kenya between March 2020 and September 2022 were associated with the Beta variant.

KenyaCOVID-19observé March 2020 – September 2022publié 2022The genomic epidemiology of SARS-CoV-2 variants of concern in Kenyaeurope_pmcdocument de 8 observationsDOI 10.1101/2022.10.26.22281446

6,3 %SARS-CoV-2 prevalence was 6.3% among persons living with HIV in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.

Kenya · Nigeria · Ouganda · TanzanieCOVID-19observé 19 July 2022 to 1 March 2024publié 2025BMC infectious diseasesPubMeddocument de 8 observations

45 introductionsLineage B.1 accounted for 45 of the 76 SARS-CoV-2 introductions into Kenyan coast.

KenyaB.1 lineage · COVID-19publié 2020Tracking the introduction and spread of SARS-CoV-2 in coastal Kenyaeurope_pmcdocument de 3 observationsDOI 10.21203/rs.3.rs-93975/v1

11 days90 (11%) of hospitalized SARS-CoV-2-infected patients were admitted to the Intensive Care Unit (ICU) for a mean of 11 days.

KenyaCOVID-19publié 2022BMJ openPubMeddocument de 7 observations

73,3 %Among 2796 reviewed COVID-19 case records in Kenya, 2049 (73.3%) were male.

KenyaCOVID-19publié 2022Journal of global healthPubMeddocument de 24 observations

74 %Lineage B.1 accounted for 74% of sequenced SARS-CoV-2 cases in coastal Kenya between 17th March and 31st July 2020.

KenyaCOVID-19observé 17th March and 31st July 2020publié 2021Nature communicationseurope_pmcdocument de 2 observations

6,8 %Prevalence at first nasal swab of SARS-CoV-2 was 6.8% among participants in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.

Kenya · Nigeria · Ouganda · TanzanieCOVID-19observé 19 July 2022 to 1 March 2024publié 2025BMC infectious diseasesPubMeddocument de 8 observations

68 %In the sample of 582 patients admitted with laboratory-confirmed COVID-19, 68% were men.

KenyaCOVID-19publié 2022PloS onePubMeddocument de 7 observations

1,32 aORSRI patients who had HIV were more likely to have SARS-CoV-2 infection compared to those who did not, with an adjusted odds ratio of 1.32.

KenyaCOVID-19 · VIH/sidaobservé July 2022 to October 2023publié 2026VaccinePubMeddocument de 8 observations

38,4 %Vaccine efficacy against asymptomatic SARS-CoV-2 infection was 38.4%.

KenyaCOVID-19publié 2023Wellcome open researcheurope_pmcdocument de 4 observations

25 %Around 25% of the SARS-CoV-2 genomes from high-income countries were submitted within 21 days.

KenyaCOVID-19publié 2022Nature communicationseurope_pmcdocument de 4 observations

73 %COVID-19 vaccination coverage was 73% among a sample of 115 pregnant women in Kenya.

KenyaCOVID-19observé 2022publié 2024International journal of environmental research and public healtheurope_pmcdocument de 5 observationsDOI 10.3390/ijerph21010098

52 casesAmong 97 SARS-CoV-2 cases in Laikipia county, Kenya, the Delta variant was detected in 52 cases.

KenyaCOVID-19observé 24th April to 31st December 2021publié 2023Temporal distribution and clinical characteristics of the Alpha, Delta and Omicron SARS-Coeurope_pmcdocument de 10 observations